MoneyWorks4Me

Sigachi Industries - Quaterly Results

30 May 2025 Evaluate
The sales surged to Rs. 1135.40 millions, up 35.72% for the March 2025 quarter as against Rs. 836.55 millions during the corresponding quarter previous year.The Net Profit of the company slipped to Rs. 69.78 millions from Rs. 117.30 millions, a decline of -40.51% on QoQ basis.Operating profit for the quarter ended March 2025 decreased to 204.66 millions as compared to 221.38 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1135.40 836.55 35.72 4078.33 3175.00 28.45 4078.33 3175.00 28.45
Other Income 17.72 71.66 -75.27 200.77 115.73 73.48 200.77 115.73 73.48
PBIDT 204.66 221.38 -7.55 943.39 708.66 33.12 943.39 708.66 33.12
Interest 28.01 24.25 15.51 106.57 70.20 51.81 106.57 70.20 51.81
PBDT 176.65 197.13 -10.39 836.82 638.46 31.07 836.82 638.46 31.07
Depreciation 39.41 27.23 44.73 129.22 87.09 48.38 129.22 87.09 48.38
PBT 137.24 169.90 -19.22 707.60 551.37 28.33 707.60 551.37 28.33
TAX 67.46 52.60 28.25 230.92 141.23 63.51 230.92 141.23 63.51
Deferred Tax 33.30 16.60 100.60 105.18 32.08 227.87 105.18 32.08 227.87
PAT 69.78 117.30 -40.51 476.68 410.14 16.22 476.68 410.14 16.22
Equity 382.12 328.20 16.43 382.12 328.20 16.43 382.12 328.20 16.43
PBIDTM(%) 18.03 26.46 -31.89 23.13 22.32 3.64 23.13 22.32 3.64
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..